Both in Pharmaceuticals
Zevra Therapeutics vs Kura Oncology
Over the past year ZVRA returned +14.1% and KURA returned −23.6%; their daily moves had a correlation of 0.18.
ZVRA +14.1% KURA −23.6%Growth of $1, one year, split-adjusted
| Metric | ZVRA | KURA |
|---|---|---|
| Price | $11.17 | $7.61 |
| Market cap | $663.3M | $677.0M |
| Today | +8.87% | −22.98% |
| 1 month | +4.1% | −27.7% |
| 6 months | −0.7% | −20.4% |
| Year to date | +24.7% | −26.8% |
| 1 year | +9.4% | −22.1% |
| Revenue growth (YoY) | +44.9% | +36.5% |
| Gross margin | 95.2% | 98.8% |
| Net margin | 48.8% | −327.3% |
| P/E (TTM) | 8.6× | — |
| Price / sales | 4.5× | 8.8× |
| Net cash | $188.3M | $509.2M |
| Dividend yield | — | — |
| Volatility (60d) | 47.6% | 76.9% |
| Short % of float | 10.8% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).